Enzon Pharmaceuticals Inc (OTCQX US:ENZN)

0.2601
Delayed Data
As of 9:30am ET
 0.00005 / +0.02%
Today’s Change
0.03
Today|||52-Week Range
0.35
-3.69%
Year-to-Date
No recent news for Enzon Pharmaceuticals Inc.

Today’s Trading

Previous close0.26
Today’s open0.26
Day’s range0.26 - 0.26
Volume2,500
Average volume (3 months)99,385
Market cap$11.5M
Data as of 9:30am ET, 04/26/2018

Growth & Valuation

Earnings growth (last year)-106.12%
Earnings growth (this year)--
Earnings growth (next 5 years)+53.00%
Revenue growth (last year)-52.01%
P/E ratio--
Price/Sales1.93
Price/Book1.11

Competitors

No competitors data available.

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$8.4M
Annual profit (last year)-$1.1M
Net profit margin-13.44%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Secretary
Andrew D. Rackear
Chief Financial &
Accounting Officer, VP-Finance
Richard L. Feinstein
Corporate headquarters
Cranford, New Jersey

Forecasts